Back to results
US 8,580,277 B2Granted
Influenza hemagglutinin and neuraminidase variants
AssigneeMedImmune, LLC
InventorsChin-Fen Yang, George Kemble, Kanta Subbaro, Brian Murphy
Life of this patent
Estimating the term…
Abstract
Polypeptides, polynucleotides, methods, compositions, and vaccines comprising (avian pandemic) influenza hemagglutinin and neuraminidase variants are provided.
Claims20
A reassortant influenza virus comprising a genome segment encoding a polypeptide comprising the amino acid sequence of SEQ ID NO:
- 39.
A method for producing reassortant influenza viruses in cell culture, the method comprising:
- i) introducing a plurality of vectors comprising polynucleotides corresponding to an influenza virus genome into a population of host cells capable of supporting replication of influenza virus, which plurality of vectors comprises polynucleotides corresponding to at least 6 internal genome segments of a first influenza strain, and at least one genome segment of a second influenza strain, wherein the at least one genome segment of the second influenza strain comprises a polynucleotide comprising a nucleotide sequence encoding the amino acid sequence of SEQ ID NO:
- 39;
- ii) culturing the population of host cells;
- and
- iii) recovering a plurality of influenza viruses.
2 more elements
Dependencies are inferred from the claim text.